Ortho Clinical Diagnostics Launches IPO at $20 to $23 Per Share

NEW YORK ─ Ortho Clinical Diagnostics on Tuesday provided additional information on its plan to go public on the Nasdaq, saying it is offering 70 million ordinary shares at an initial public offering price expected to be between $20.00 and $23.00 per share, which would amount to between $1.4 billion and $1.61 billion in gross proceeds.